Challenges, Preparations, and Recommendations: Family Perspectives on Pediatric Cardiac Surgery Across Childhood and

Sarah E Wawrzynski1, Erica Sood1,2, Kelsey Higgins1

  • 1Nemours Children's Health, Wilmington, DE, USA.

Insights

Families of children aged 3-17 undergoing cardiac surgery face challenges with support, communication, and emotions. Enhancing communication and providing resources can empower families during hospitalization and recovery.

Area of Science:

  • Pediatric Cardiology
  • Child Psychology
  • Healthcare Family Support

Background:

  • Congenital heart disease (CHD) is a common global birth defect requiring surgical intervention.
  • While infant cardiac surgery stress is known, family experiences with older children (3-17 years) are less understood.

Purpose of the Study:

  • To explore the experiences of families with children aged 3-17 hospitalized for cardiac surgery.
  • To identify challenges, preparations, and recommendations for supporting these families.

Main Methods:

  • Qualitative content and thematic analysis of semi-structured interviews.
  • Participants included 32 parents and 14 patients (children aged 3-17).

Main Results:

  • Seven themes emerged across challenges (support disruption, communication issues, emotional uncertainty), preparations (emotional and logistical planning), and recommendations (improved communication, resources, education).
  • Key challenges involved disruptions in social support, unexpected events, and emotional distress.

Conclusions:

  • Families require targeted interventions to address challenges related to communication, support systems, and emotional well-being.
  • Empowering families through resources and education is crucial for managing hospitalization and recovery for children with CHD.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
804
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
963
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552